HER2-Negative Breast Cancer Active Not Recruiting Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0072181 (HER2-Negative Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment